Close Menu

At Science Progress, Britt Holbrook points out that the America COMPETES Reauthorization Act of 2010 is waiting to be voted on, and that while everyone seemed to be fixated on its $84 billion price tag, there is an overlooked aspect of the bill: its attempt to clarify the National Science Foundation's Broader Impacts Criterion policy. A subsection of this bill aims to explain what "broader impact" means by listing goals and policy recommendations.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.